PPL vs TERN · P/E 22, rev $8.46B vs $6.12B cap
PPL Corporation (PPL) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
PPL currently screens at market cap $26.58B and trailing P/E 21.7. TERN currently screens at market cap $6.12B.
Not investment advice. Open the PPL and TERN stock pages for the full models.
Not investment advice.